SAN DIEGO, November 12, 2019 – ProSciento, Inc., a clinical research organization (CRO) exclusively focused on diabetes, NASH, obesity and related metabolic diseases, will present clinical research data at the 19th Annual Diabetes Technology Meeting, November 14-16 in North Bethesda, Maryland.
Poster presentations by ProSciento:
- Glucose Clamp Quality Parameters Among Study Populations
Authors: Alejandra Macias Pulido, MD; Linda Morrow, MD; Gabriela Campos-Cortes, MD; Julie Willard, MD; Moises Hernandez, MD; Marcus Hompesch, MD
- Effect of Dawn Phenomenon on Glucose Infusion Rate During Glucose Clamp Studies in Subjects with Type 1 Diabetes
Authors: Bridgette Boggess Franey, MD; Alejandra Macias Pulido, MD; Linda Morrow, MD; Marcus Hompesch, MD
About ProSciento, Inc.
ProSciento is a highly specialized clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity and related metabolic diseases. ProSciento works with biopharma companies worldwide to support their outsourced clinical research needs with comprehensive and customized services for multinational, early development clinical trial programs. Founded in 2003, ProSciento has conducted more than 280 clinical projects for diabetes, NASH and obesity and supported the development of many approved metabolic drugs and devices on the market globally. For more information, please visit www.prosciento.com.
For business development inquiries, please contact:
For media inquiries, please contact:
Senior Director, Corporate Communications, ProSciento, Inc.
For clinical trial enrollment inquires:
Tel: +1 (866) 308-7427